Trial intelligence / Profile preview

HERO: Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis

2011-004300-38Phase 3Completed

Sponsor
University of Leeds
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hand osteoarthritis comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoint: Change in hand pain severity at 6 months. Started May 2012; status: completed.

02

Drugs

hydroxychloroquine
03

Conditions

hand osteoarthritis

Beyond the preview

Go deeper on 2011-004300-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004300-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call